MEDICINA
Departamento
Mount Sinai Hospital
Toronto, CanadáPublicaciones en colaboración con investigadores/as de Mount Sinai Hospital (6)
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458
2015
-
Outcomes of estrogen receptor negative and progesterone receptor positive breast cancer
PLoS ONE, Vol. 10, Núm. 7
2012
-
Management of treatment-emergent peripheral neuropathy in multiple myeloma
Leukemia, Vol. 26, Núm. 4, pp. 595-608
2008
-
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Virus Research, Vol. 133, Núm. 1, pp. 13-19
2007
-
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Journal of Virology, Vol. 81, Núm. 16, pp. 8692-8706